{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:11:53Z","timestamp":1776708713824,"version":"3.51.2"},"reference-count":143,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008389","name":"Research Institute of Clinical and Experimental Lymphology\u2014Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences","doi-asserted-by":"publisher","award":["FWNR-2023-0008"],"award-info":[{"award-number":["FWNR-2023-0008"]}],"id":[{"id":"10.13039\/100008389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Among cardiovascular diseases, chronic obliterating lesions of the arteries of lower extremities, which are one of the important problems of modern healthcare, are distinguished. In most cases, the cause of damage to the arteries of lower extremities is atherosclerosis. The most severe form is chronic ischemia, characterized by pain at rest and ischemic ulcers, ultimately increasing the risk of limb loss and cardiovascular mortality. Therefore, patients with critical limb ischemia need limb revascularization. Percutaneous transluminal balloon angioplasty is one of the least invasive and safe approaches, with advantages for patients with comorbidities. However, after this procedure, restenosis is still possible. Early detection of changes in the composition of some molecules as markers of restenosis will help screen patients at the risk of restenosis, as well as find ways to apply efforts for further directions of inhibition of this process. The purpose of this review is to provide the most important and up-to-date information on the mechanisms of restenosis development, as well as possible predictors of their occurrence. The information collected in this publication may be useful in predicting outcomes after surgical treatment and will also find new ways for the target implication to the mechanisms of development of restenosis and atherosclerosis.<\/jats:p>","DOI":"10.3390\/ijms24109096","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:20:06Z","timestamp":1684812006000},"page":"9096","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-6342","authenticated-orcid":false,"given":"Elvira V.","family":"Sobolevskaya","sequence":"first","affiliation":[{"name":"Laboratory of Surgical Lymphology and Lymph-Detoxication, Research Institute of Clinical and Experimental Lymphology\u2014Branch of the Institute of Cytology and Genetics, SB RAS, Novosibirsk 630117, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg A.","family":"Shumkov","sequence":"additional","affiliation":[{"name":"Laboratory of Surgical Lymphology and Lymph-Detoxication, Research Institute of Clinical and Experimental Lymphology\u2014Branch of the Institute of Cytology and Genetics, SB RAS, Novosibirsk 630117, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail A.","family":"Smagin","sequence":"additional","affiliation":[{"name":"Laboratory of Surgical Lymphology and Lymph-Detoxication, Research Institute of Clinical and Experimental Lymphology\u2014Branch of the Institute of Cytology and Genetics, SB RAS, Novosibirsk 630117, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1028-9958","authenticated-orcid":false,"given":"Andrey E.","family":"Guskov","sequence":"additional","affiliation":[{"name":"Laboratory of Scientometrics and Scientific Communications, Russian Research Institute of Economics, Politics and Law in Science and Technology, Moscow 127254, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra V.","family":"Malysheva","sequence":"additional","affiliation":[{"name":"Laboratory of Scientometrics and Scientific Communications, Russian Research Institute of Economics, Politics and Law in Science and Technology, Moscow 127254, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-5604","authenticated-orcid":false,"given":"Victor V.","family":"Atuchin","sequence":"additional","affiliation":[{"name":"Laboratory of Optical Materials and Structures, Institute of Semiconductor Physics, SB RAS, Novosibirsk 630090, Russia"},{"name":"Research and Development Department, Kemerovo State University, Kemerovo 650000, Russia"},{"name":"Department of Industrial Machinery Design, Novosibirsk State Technical University, Novosibirsk 630073, Russia"},{"name":"R&D Center \u201cAdvanced Electronic Technologies\u201d, Tomsk State University, Tomsk 634034, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-3729","authenticated-orcid":false,"given":"Vadim V.","family":"Nimaev","sequence":"additional","affiliation":[{"name":"Laboratory of Surgical Lymphology and Lymph-Detoxication, Research Institute of Clinical and Experimental Lymphology\u2014Branch of the Institute of Cytology and Genetics, SB RAS, Novosibirsk 630117, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"ref_1","first-page":"56","article-title":"Methodology for selecting publications for scientific reviews","volume":"11","author":"Malysheva","year":"2022","journal-title":"Sci. Tech. Libr."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Signorelli, S.S., Marino, E., Scuto, S., and Di Raimondo, D. (2020). Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124393"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cjca.2022.02.029","article-title":"Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease","volume":"38","author":"Abramson","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/clc.22657","article-title":"Impact of diabetes on mortality in peripheral artery disease: A meta-analysis","volume":"40","author":"Vrsalovic","year":"2017","journal-title":"Clin. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","article-title":"Epidemiology of Diabetes Mellitus and Cardiovascular Disease","volume":"21","author":"Glovaci","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","article-title":"Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD","volume":"128","author":"Beckman","year":"2021","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.carrev.2018.10.028","article-title":"Endovascular Management of Femoropopliteal In-Stent Restenosis: A Systematic Review","volume":"20","author":"Varela","year":"2019","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/07853890310014876","article-title":"Inflammation and restenosis: Implications for therapy","volume":"35","author":"Donners","year":"2003","journal-title":"Ann. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/17434440.2020.1770593","article-title":"Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis","volume":"17","author":"Love","year":"2020","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/01.CIR.94.11.2890","article-title":"Virus-Encoded Serine Proteinase Inhibitor SERP-1 Inhibits Atherosclerotic Plaque Development After Balloon Angioplasty","volume":"94","author":"Lucas","year":"1996","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.82.6.2190","article-title":"Restenosis after balloon angioplasty. A practical proliferative model in the porcine coronary arteries","volume":"82","author":"Schwartz","year":"1990","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI117078","article-title":"Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty","volume":"93","author":"Villa","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/01.CIR.93.12.2178","article-title":"Identification of a Potential Role for the Adventitia in Vascular Lesion Formation After Balloon Overstretch Injury of Porcine Coronary Arteries","volume":"93","author":"Scott","year":"1996","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amjsurg.2017.01.028","article-title":"Diabetes and peripheral artery disease: A bad combination","volume":"216","author":"Vrsalovic","year":"2017","journal-title":"Am. J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/jama.2012.13415","article-title":"Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men","volume":"308","author":"Joosten","year":"2012","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","article-title":"Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications","volume":"30","author":"Domingueti","year":"2016","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4239\/wjd.v6.i7.961","article-title":"Peripheral Artery Disease in Patients with Diabetes: Epidemiology, Mechanisms, and Outcomes","volume":"6","author":"Thiruvoipati","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"(2003). American Diabetes Association Peripheral Arterial Disease in People with Diabetes. Diabetes Care, 26, 3333\u20133341.","DOI":"10.2337\/diacare.26.12.3333"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: Epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"340.e1","DOI":"10.1016\/j.amjmed.2015.09.022","article-title":"Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c","volume":"129","author":"Cavender","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.jacc.2018.09.078","article-title":"Cardiovascular and Limb Outcomes in Patients with Diabetes and Peripheral Artery Disease: The EUCLID Trial","volume":"72","author":"Wang","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jvn.2019.12.002","article-title":"Review of article: Goldman M.P., Clark C.J., Craven T.E., Davis R.P., Williams T.K., Velazquez-Ramirez G., Hurie J.B., Edwards M.S. Effect of intensive glycemic control on risk of lower extremity amputation. J Am Coll Surg 2018; 227: 596\u2013604","volume":"37","year":"2019","journal-title":"J. Vasc. Nurs."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/dc10-0939","article-title":"The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia","volume":"33","author":"Takahara","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X14538330","article-title":"Association of Elevated Fasting Glucose with Lower Patency and Increased Major Adverse Limb Events among Patients with DI-Abetes Undergoing Infrapopliteal Balloon Angioplasty","volume":"19","author":"Singh","year":"2014","journal-title":"Vasc. Med."},{"key":"ref_27","first-page":"9","article-title":"The role of vascular surgery in the multidisciplinary approach to the diabetic foot syndrome","volume":"11","author":"Shumkov","year":"2013","journal-title":"Khirurgiia"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Smagin, M., Shumkov, O., Khapaev, R., Surovtseva, M., and Nimaev, V. (2020, January 6\u201310). The combined approach to treatment of patients witn chronic ischemia and diabetic foot syndrome. Proceedings of the 2020 Cognitive Sciences, Genomics and Bioinformatics (CSGB), Novosibirsk, Russia.","DOI":"10.1109\/CSGB51356.2020.9214696"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4070\/kcj.2017.0157","article-title":"Formation and Transformation of Neointima after Drug-eluting Stent Implantation: Insights from Optical Coherence Tomographic Studies","volume":"47","author":"Lee","year":"2017","journal-title":"Korean Circ. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12928-020-00734-7","article-title":"Mechanisms of drug-eluting stent restenosis","volume":"36","author":"Aoki","year":"2021","journal-title":"Cardiovasc. Interv. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tummala, S., Amin, A., and Mehta, A. (2020). Infrapopliteal Artery Occlusive Disease: An Overview of Vessel Preparation and Treatment Options. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103321"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","article-title":"Inflammation and type 2 diabetes","volume":"38","author":"Calle","year":"2012","journal-title":"Diabetes Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Saik, O., Sobolevskaya, E., Khapaev, R., Shumkov, O., Smagin, M., and Nimaev, V. (2022, January 11\u201313). Revealing the Molecular Basis of Vascular Restenosis by Gene Network Analysis. Proceedings of the 2022 IEEE International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON 2022), Yekaterinburg, Russia.","DOI":"10.1109\/SIBIRCON56155.2022.10016949"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0041-1731663","article-title":"Endothelial progenitor cells modulate the phenotype of smooth muscle cells and increase their neointimal accumulation following vascular injury","volume":"122","author":"Mause","year":"2022","journal-title":"Thromb. Haemost."},{"key":"ref_35","first-page":"E198","article-title":"The Biology of In-Stent Restenosis and the Rationale for Debulking","volume":"13","year":"2016","journal-title":"Vasc. Dis. Manag."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/mva.2002.122021","article-title":"Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease","volume":"35","author":"Inoue","year":"2002","journal-title":"J. Vasc. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ccd.23064","article-title":"Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses","volume":"78","author":"Iida","year":"2011","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-Stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia","volume":"31","author":"Kornowski","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1161\/ATVBAHA.115.306251","article-title":"Neoatherosclerosis from a Pathologist\u2019s Point of View","volume":"35","author":"Romero","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41569-018-0106-9","article-title":"The role of B cells in atherosclerosis","volume":"16","author":"Sage","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","article-title":"Necrotic cell death in atherosclerosis","volume":"106","author":"Martinet","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Vesnina, A., Prosekov, A., Atuchin, V., Minina, V., and Ponasenko, A. (2022). Tackling Atherosclerosis via Selected Nutrition. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158233"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2019.03.016","article-title":"Neoatherosclerosis\u2014From basic concept to clinical implication","volume":"178","author":"Mazin","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molimm.2022.06.003","article-title":"Myeloid PHD2 deficiency accelerates neointima formation via Hif-1\u03b1","volume":"149","author":"Christoph","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"670653","DOI":"10.3389\/fphys.2021.670653","article-title":"Hypoxia-Inducible Factor Regulates Endothelial Metabolism in Cardiovascular Disease","volume":"12","author":"Ullah","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Miroshnichenko, S., Usynin, I., Dudarev, A., Nimaev, V., and Solovieva, A. (2020). Apolipoprotein A-I supports MSCS survival under stress conditions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114062"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/ATVBAHA.113.302642","article-title":"Has our understanding of calcification in human coronary atherosclerosis progressed?","volume":"34","author":"Otsuka","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/ATVBAHA.114.304000","article-title":"Recent highlights of ATVB: Calcification","volume":"34","author":"Virmani","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","article-title":"Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis","volume":"13","author":"Yahagi","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vph.2018.08.002","article-title":"Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease","volume":"112","author":"Maguire","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2009.07.016","article-title":"Innate immune signals in atherosclerosis","volume":"134","author":"Lundberg","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting Stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.CIR.0000139337.56084.30","article-title":"Extracellular Matrix Changes in Stented Human Coronary Arteries","volume":"110","author":"Farb","year":"2004","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur. Hear. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ecl.2006.06.002","article-title":"Diabetic dyslipidemia","volume":"35","author":"Chahil","year":"2006","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25F","DOI":"10.1016\/S0002-9149(99)00211-8","article-title":"Hypertriglyceridemia, insulin resistance, and the metabolic syndrome","volume":"83","author":"Grundy","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.ATV.0000125114.88079.96","article-title":"Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis","volume":"24","author":"Kawashima","year":"2004","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet Dysfunction in Type 2 Diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am. Heart J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"Verbeuren","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/dmrr.2232","article-title":"Arteriogenesis versus angiogenesis in peripheral artery disease","volume":"28","author":"Troidl","year":"2012","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2337\/diabetes.50.4.851","article-title":"Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels","volume":"50","author":"Suzuki","year":"2001","journal-title":"Diabetes"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0006-291X(87)80299-1","article-title":"The role of nitric oxide and cGMP inplatelet adhesion to vascular endothelium","volume":"148","author":"Radomski","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00125-002-0800-2","article-title":"Vascular function, insulin resistance and fatty acids","volume":"45","author":"Steinberg","year":"2002","journal-title":"Diabetologia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.78.2.225","article-title":"Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle Cells","volume":"78","author":"Sarkar","year":"1996","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hh1201.092042","article-title":"Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress","volume":"88","author":"Uemura","year":"2001","journal-title":"Circ Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular Inflammation and Repair: Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1253\/circj.CJ-12-0801","article-title":"Inflammation and Vascular Injury","volume":"76","author":"Simon","year":"2012","journal-title":"Circ. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cyto.2014.02.014","article-title":"An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis","volume":"67","author":"Demyanets","year":"2014","journal-title":"Cytokine"},{"key":"ref_75","first-page":"73","article-title":"Restenosis after percutaneous angioplasty: The role of vascular inflammation","volume":"1","author":"Schillinger","year":"2005","journal-title":"Vasc. Risk. Manag."},{"key":"ref_76","first-page":"III47","article-title":"A cascade model for restenosis. A special case of atherosclerosisprogression","volume":"86","author":"Libby","year":"1992","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.avsg.2017.11.064","article-title":"The Role of Interleukins and Inflammatory Markers in the Early Restenosis of Covered Stents in the Femoropopliteal Arterial Segment","volume":"50","author":"Guimaraes","year":"2018","journal-title":"Ann. Vasc. Surg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.avsg.2014.12.006","article-title":"Interleukins and Inflammatory Markers in In-Stent Restenosis after Femoral Percutaneous Transluminal Angioplasty","volume":"29","author":"Ribeiro","year":"2015","journal-title":"Ann. Vasc. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"H1200","DOI":"10.1152\/ajpheart.00268.2009","article-title":"Established neointimal hyperplasia in vein grafts expands via TGF-\u03b2-mediated progressive fibrosis","volume":"297","author":"Jiang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/0003319716633339","article-title":"Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study","volume":"67","author":"Signorelli","year":"2016","journal-title":"Angiology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jvs.2005.03.025","article-title":"Inflammatory mediators are associated with 1-year mortality in critical limb ischemia","volume":"42","author":"Barani","year":"2005","journal-title":"J. Vasc. Surg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvs.2021.02.026","article-title":"A systematic review and meta-analysis on the association between C-reactive protein levels and adverse limb events after revascularization in patients with peripheral arterial disease","volume":"74","author":"Di","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1526602815573226","article-title":"C-reactive protein and endovascular treatment of lower limb peripheral artery disease: An independent prognostic factor","volume":"22","author":"Bleda","year":"2015","journal-title":"J. Endovasc. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejvs.2017.05.009","article-title":"Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease","volume":"54","author":"Singh","year":"2017","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiol.2272020137","article-title":"Endovascular Revascularization Below the Knee: 6-month Results and Predictive Value of C-reactive Protein Level","volume":"227","author":"Schillinger","year":"2003","journal-title":"Radiology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diabres.2010.08.002","article-title":"C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers","volume":"90","author":"Lin","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.avsg.2012.02.027","article-title":"Inflammatory Burden Predicts Long-Term Outcomes in Endovascular Therapy in Peripheral Arterial Disease","volume":"27","author":"Bleda","year":"2013","journal-title":"Ann. Vasc. Surg."},{"key":"ref_88","first-page":"47","article-title":"Inflammatory markers in peripheral arterial disease patients after endovascular revascularization with new restenosis","volume":"20","author":"Kotschy","year":"2014","journal-title":"Acta Angiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/dc19-0408","article-title":"Inflammatory Cytokines Associated with Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population with Diabetes","volume":"42","author":"Biscetti","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1161\/STROKEAHA.111.619288","article-title":"Assessment of the Genetic Effects of Polymorphisms in the Osteoprotegerin Gene, TNFRSF11B, on Serum Osteoprotegerin Levels and Carotid Plaque Vulnerability","volume":"42","author":"Straface","year":"2011","journal-title":"Stroke"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"182060","DOI":"10.1155\/2013\/182060","article-title":"Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients","volume":"2013","author":"Augoulea","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00592-014-0664-1","article-title":"TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes","volume":"51","author":"Biscetti","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-017-0581-z","article-title":"Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects","volume":"16","author":"Giovannini","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","article-title":"A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis","volume":"219","author":"Protogerou","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/157339910790442628","article-title":"The Connection between C-Reactive Protein (CRP) and Diabetic Vasculopathy. Focus on Preclinical Findings","volume":"6","author":"Li","year":"2010","journal-title":"Curr. Diabetes Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1756-8722-6-61","article-title":"An evolving new paradigm: Endothelial cells\u2014Conditional innate immune cells","volume":"6","author":"Mai","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.200424916","article-title":"Mini-Review: The Nuclear Protein hmgb1 as a Proinflammatory Mediator","volume":"34","author":"Erlandsson","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.carpath.2004.03.289","article-title":"Increased Expression of the Dna-Binding Cytokine HMBG1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines","volume":"13","author":"Kalinina","year":"2004","journal-title":"Cardiovasc. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/db09-1507","article-title":"High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism","volume":"59","author":"Biscetti","year":"2010","journal-title":"Diabetes"},{"key":"ref_100","first-page":"157","article-title":"Usefulness of high mobility group box 1 protein as a plasma biomarker in patient with peripheral artery disease","volume":"68","author":"Oozawa","year":"2014","journal-title":"Acta Med. Okayama"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2008.04.019","article-title":"Predictive value of elevated neutrophil\u2013lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease","volume":"395","author":"Papa","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.carrev.2008.01.003","article-title":"Association between C-reactive protein and angiographic restenosis after bare metal stents: An updated and comprehensive meta-analysis of 2747 patients","volume":"9","author":"Ferrante","year":"2008","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0008-6363(03)00355-9","article-title":"Preprocedural serum levels of acute phase reactants and prognosis after percutaneous coronary intervention","volume":"60","author":"Rahel","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.amjcard.2012.07.003","article-title":"Usefulness of the Neutrophil-to-Lymphocyte Ratio to Predict Bare-Metal Stent Restenosis","volume":"110","author":"Turak","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0003319717714918","article-title":"The Relationship Between the Neutrophil-Lymphocyte Ratio and In-Stent Restenosis in Patients with Femoropopliteal Chronic Total Occlusions","volume":"69","author":"Chang","year":"2018","journal-title":"Angiology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"BSR20193448","DOI":"10.1042\/BSR20193448","article-title":"The relationship between neutrophil\u2013lymphocyte ratio and in-stent restenosis in superficial femoral artery","volume":"40","author":"Yang","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jvs.2014.03.277","article-title":"Neutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia","volume":"60","author":"Chan","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lee, S., Hoberstorfer, T., Wadowski, P.P., Kopp, C.W., Panzer, S., and Gremmel, T. (2020). Platelet-to-lymphocyte and Neutrophil-to-lymphocyte ratios predict target vessel restenosis after infrainguinal angioplasty with stent implantation. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061729"},{"key":"ref_109","first-page":"627","article-title":"Below-the-knee revascularization. Advanced techniques","volume":"50","author":"Schwarzwalder","year":"2009","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3577761","DOI":"10.1155\/2022\/3577761","article-title":"Association between Oxidative Burden and Restenosis: A Case-Control Study","volume":"2022","author":"Ganjali","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejvs.2003.11.001","article-title":"Selected haemostatic factors in carotid bifurcation plaques of patients undergoing carotid endarterectomy","volume":"27","author":"Migdalski","year":"2004","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejvs.2005.02.055","article-title":"Tissue Factor, Tissue Factor Pathway Inhibitor and Vascular Endothelial Growth Factor-A in Carotid Atherosclerotic Plaques","volume":"30","author":"Migdalski","year":"2005","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: A perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"ref_114","first-page":"1158","article-title":"Rola czynnika tkankowego i jego inhibitora w procesie krzepni\u0119cia krwioraz w powik\u0142aniach zakrzepowych","volume":"10","author":"Kotschy","year":"2010","journal-title":"Kardiol. Pol."},{"key":"ref_115","first-page":"35","article-title":"Plasma levels of the molecular markers of coagulation and fibrinolysis inpatients with peripheral arterial disease","volume":"22","author":"Strano","year":"1996","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_116","first-page":"H603","article-title":"Surface thrombomodulin modulatestrombin receptor responses on vascular smooth muscle cells","volume":"270","author":"Grinnel","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_117","first-page":"107","article-title":"Von Willebrandfactor and endothelial damage in essential hypertension","volume":"7","author":"Blann","year":"1993","journal-title":"J. Hum. Hypertens."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovasculardiseases: Molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1510\/icvts.2006.136507","article-title":"Impact of blood coagulationand fibrinolytic system changes on early and mid term clinical outcomein patients undergoing stent endografting surgery","volume":"5","author":"Monaco","year":"2006","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.17219\/acem\/38160","article-title":"Tissue Factor and Other Hemostatic Parameters in Patients with Advanced Peripheral Artery Disease After Endovascular Revascularization\u2014Search for Hemostatic Factors which Indicate Restenosis","volume":"24","author":"Kotschy","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5758\/vsi.210010","article-title":"Coagulation Factor Activity and Hemostatic Markers of Endothelial Dysfunction in Patients with Peripheral Arterial Disease","volume":"37","author":"Kalinin","year":"2021","journal-title":"Vasc. Spe\u00e9c. Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5604\/17322693.1164409","article-title":"Wybrane \u015br\u00f3db\u0142onkowe markery hemostazy u pacjent\u00f3w z mia\u017cd\u017cyc\u0105 t\u0119tnic ko\u0144czyn dolnych po wewn\u0105trznaczyniowej rewaskularyzacji i po powstaniu restenoz [Selected endothelial hemostatic markers in patients with peripheral arterial disease after endovascular revascularization and restenosis formation]","volume":"69","author":"Kotschy","year":"2015","journal-title":"Post\u0119py Hig. Med. Dosw."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1423-0127-19-79","article-title":"Roles of microRNAs in atherosclerosis and restenosis","volume":"19","author":"Chen","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"ref_125","first-page":"794898","article-title":"MicroRNAs in Vascular Biology","volume":"2012","author":"Yamakuchi","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.115.308237","article-title":"MicroRNAs for Restenosis and Thrombosis after Vascular Injury","volume":"118","author":"Gareri","year":"2016","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tcm.2012.08.004","article-title":"Vascular miRNAs After Balloon Angioplasty","volume":"23","author":"Polimeni","year":"2013","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2018.01.020","article-title":"Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation","volume":"269","author":"Stojkovic","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.SRJ05001X","article-title":"The Kallikrein-Kinin System: Current and Future Pharmacological Targets","volume":"99","author":"Moreau","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1020714518246","article-title":"Angiotensin II and nitric oxide interaction","volume":"7","year":"2002","journal-title":"Heart Fail. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jvs.2016.06.106","article-title":"The role of the kallikrein-kinin system, matrix metalloproteinases, and tissue inhibitors of metalloproteinases in the early restenosis of covered stents in the femoropopliteal arterial segment","volume":"65","author":"Rocha","year":"2017","journal-title":"J. Vasc. Surg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardiores.2005.08.002","article-title":"Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates","volume":"69","author":"Newby","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2011.05.005","article-title":"Matrix metalloproteinase inhibitor properties of tetracyclines: Therapeutic potential in cardiovascular diseases","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.phrs.2011.04.002","article-title":"Matrix metal- loproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"928315","DOI":"10.1155\/2013\/928315","article-title":"Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling","volume":"2013","author":"Chen","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-10-76","article-title":"Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus","volume":"10","author":"Poulsen","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/14017431.2012.685491","article-title":"Osteoprotegerin as a marker of atherosclerosis: A systematic update","volume":"46","author":"Hosbond","year":"2012","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12933-022-01605-6","article-title":"Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease","volume":"21","author":"Kadoglou","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1534734619898097","article-title":"Association of Circulating Osteopontin Levels with Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study","volume":"19","author":"Eleftheriadou","year":"2020","journal-title":"Int. J. Low. Extremity Wounds"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9096\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:40:03Z","timestamp":1760125203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":143,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24109096"],"URL":"https:\/\/doi.org\/10.3390\/ijms24109096","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}